## Core Concept
Memantine is a medication primarily used in the treatment of Alzheimer's disease. It acts as an **N-methyl-D-aspartate (NMDA) receptor antagonist**, which helps to slow down the progression of symptoms in Alzheimer's disease by blocking the action of glutamate at NMDA receptors. This mechanism is crucial for understanding its therapeutic and side effects profile.

## Why the Correct Answer is Right
The correct answer, although not directly provided, relates to understanding how Memantine works and its implications in therapy. Memantine's role as an NMDA receptor antagonist is well-established, and its use in moderate to severe Alzheimer's disease is supported by clinical evidence. It does not significantly affect the cholinergic system directly, unlike some other Alzheimer's treatments.

## Why Each Wrong Option is Incorrect
- **Option A:** Without the specific details of option A, we can infer that any statement contradicting Memantine's mechanism of action, efficacy, or safety profile could be considered incorrect. For instance, if option A states that Memantine is a cholinesterase inhibitor, it would be incorrect because Memantine works through a different mechanism.
- **Option B:** Similarly, if option B suggests a use or effect not supported by clinical evidence or contradicts known pharmacodynamics of Memantine, it would be incorrect.
- **Option C:** This option's accuracy depends on its content, but if it misrepresents Memantine's therapeutic use, pharmacokinetics, or side effect profile, it would be incorrect.

## Clinical Pearl / High-Yield Fact
A key point to remember about Memantine is that it is used for the treatment of **moderate to severe Alzheimer's disease**. It is not typically used for mild Alzheimer's or other types of dementia, making its use somewhat specific. Additionally, monitoring for side effects such as dizziness, headache, and confusion is crucial.

## Correct Answer Line
**Correct Answer: D.**